Particle Sciences adds sterile powder and capsule filling capabilities
Powder fills from 50mg to 75g, with an accuracy of up to +/-1% of fill volume, are now possible
The Lubrizol Corporation’s LifeSciences business has added cGMP sterile powder and capsule filling at its Particle Sciences facility.
The firm said this move is in response to increased demand from clients for cGMP powder handling in both vials and proprietary devices.
'There has been an uptick in our partners’ need for sterile powder filling, both in vials and proprietary devices. To meet this need, we have acquired and qualified the necessary equipment,' said Robert Lee, Vice President of Pharmaceutical Development Services.
Powder fills from 50mg to 75g, with an accuracy of up to +/-1% of fill volume, are now possible, including those for highly potent compounds.
As a leading developer of particulates, using both standard and proprietary approaches, the Particle Sciences’ facility is supported by full development and analytic services. As previously announced, commercial production at that location will come online in 2017.
Lee added: 'Also included in this latest capability expansion is capsule filling. With a clinical supply capability of 3,000 capsules (sizes 0–4) per hour, we are positioned to assist our clients in utilising our bioavailability-enhancing platforms in oral dosage forms.'
Particle Sciences was founded in 1991 and is headquartered in Bethlehem, Pennsylvania, US.
